Rosalind Advisors, Inc.
35 holdingsFiling period: 2026-06-30Current AUM: $281.4Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | DCTH | Delcath Systems, Inc. | 3.30M | $41.6M | $47.9M | 17.02% | -- | 2026-06-30 |
| 2 | FENC | Fennec Pharmaceuticals Inc | 3.19M | $34.3M | $32.4M | 11.50% | +279.8K | 2026-06-30 |
| 3 | XERS | Xeris Biopharma Holdings Inc | 2.91M | $23.0M | $29.7M | 10.55% | -322,719 | 2026-06-30 |
| 4 | SVRA | Savara Inc | 3.18M | $19.6M | $14.4M | 5.10% | -25,600 | 2026-06-30 |
| 5 | VSTM | Verastem Inc | 3.99M | $15.2M | $39.9M | 14.17% | +1.85M | 2026-06-30 |
| 6 | XFOR | X4 Pharmaceuticals Inc | 3.21M | $15.0M | $10.4M | 3.71% | -- | 2026-06-30 |
| 7 | EYPT | Eyepoint Pharmaceuticals Inc | 988.2K | $14.1M | $361K | 0.13% | -48,507 | 2026-06-30 |
| 8 | HELP | Cybin Inc | 1.96M | $12.9M | $20.3M | 7.20% | +425.0K | 2026-06-30 |
| 9 | VOR | Vor Biopharma Inc | 648.6K | $11.9M | $11.9M | 4.22% | -51,400 | 2026-06-30 |
| 10 | PCVX | Vaxcyte Inc | 200.0K | $11.6M | $12.0M | 4.26% | -90,000 | 2026-06-30 |
| 11 | — | Mediwound Ltd | 749.1K | $11.0M | $11.0M | 3.91% | -- | 2026-06-30 |
| 12 | CLDX | Celldex Therapeutics Inc | 200.0K | $7.4M | $5.9M | 2.10% | -130,000 | 2026-06-30 |
| 13 | BCRX | Biocryst Pharmaceuticals Inc | 721.5K | $7.2M | $5.7M | 2.02% | -201,553 | 2026-06-30 |
| 14 | PROF | Profound Medical Corp | 828.1K | $5.5M | $4.6M | 1.63% | -- | 2026-06-30 |
| 15 | TLPH | Talphera Inc | 5.17M | $5.3M | $5.5M | 1.97% | +1.82M | 2026-06-30 |
| 16 | AVIR | Atea Pharmaceuticals Inc | 1.07M | $5.0M | $4.5M | 1.58% | -101,305 | 2026-06-30 |
| 17 | MYO | Myomo Inc | 3.64M | $3.8M | $4.4M | 1.55% | -209,386 | 2026-06-30 |
| 18 | OVID | Ovid Therapeutics Inc | 1.11M | $3.0M | $2.4M | 0.85% | -- | 2026-06-30 |
| 19 | NRXS | Neuraxis Inc | 508.1K | $3.0M | $2.9M | 1.05% | +221.9K | 2026-06-30 |
| 20 | ABVX | Abivax SA | 20.9K | $2.8M | $1.8M | 0.64% | -- | 2026-06-30 |
| 21 | NSPR | Inspiremd Inc | 3.91M | $2.7M | $1.8M | 0.62% | -- | 2026-06-30 |
| 22 | — | Regentis Biomaterials Ltd | 701.7K | $2.5M | $2.5M | 0.88% | +450.2K | 2026-06-30 |
| 23 | SLS | Sellas Life Sciences Group Inc | 568.7K | $2.3M | $1.8M | 0.63% | -- | 2026-06-30 |
| 24 | — | Polypid Ltd | 389.5K | $2.0M | $2.0M | 0.70% | -208,471 | 2026-06-30 |
| 25 | BFRI | Biofrontera Inc | 1.28M | $1.2M | $1.0M | 0.37% | +111.6K | 2026-06-30 |
← Scroll →
Page 1 of 2